welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Eugene Gerner, PhD
Gastrointestinal Cancer Program
Arizona Cancer Center
Places : The University of Arizona Cancer Center
CEO, Cancer Prevention Pharmaceuticals (CPP)
Cancer Prevention Pharmaceuticals (CPP) is a company in the late stages of developing drugs and drug combinations to treat people with risk factors for cancer. Some of these people have genetic risk factors, such as defects in the adenomatous poly posits coli tumor suppressor gene which cause the familial adenomatous polyposis (FAP) syndrome. Others have sporadic risk factors, such as prior colorectal cancer or neuroblastoma with amplified copies of the MYCN oncogene. CPP is also developing companion diagnostics for its drug therapies.
expertly curated content related to this topic
Siteman Cancer CenterSiteman Cancer Center's specialized onco...
steven nasioulasLaboratory Services Manager...
Revealing the Power of the Rare Disease Community With State-of-the Art Collaborative, Trustworthy, Digital Educatio...The growth of online communities in ...
Paul E. Wise, MDAffiliations: Barnes-Jewish Hospital, B...
Niloy J. Samadder, MDDr. Samadder received his medical degree...
Timothy S. Sadiq, MDAssociate Professor of Surgery at Univer...
A Study of Guselkumab in Participants With Familial Adenomatous PolyposisThe purpose of this study is to determin...